DOI:
10.1055/s-00000030
Der Klinikarzt
LinksClose Window
References
Richardson PG, Baz R, Wang L, Jakubowiak AJ et al.
Investigational Agent MLN9708, An Oral Proteasome Inhibitor, in Patients (Pts) with Relapsed and/or Refractory Multiple Myeloma (MM): Results From the Expansion Cohorts of a Phase 1 Dose-Escalation Study.
ASH Annual Meeting Abstracts 2011;
118: 301-301
Search in:
We do not assume any responsibility for the contents of the web pages of other providers.